Savient Pharmaceuticals (SVNT) Inactive 10-K2007 FY Annual report

Filed: 14 Mar 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abuse, acknowledgement, adding, advice, affiliated, affirmed, antihistamine, argument, arose, Asia, attained, behavior, Berger, BOA, Branch, carefully, Carlo, carryback, China, choice, clearer, Columbia, Compensationand, compliment, conference, convenience, County, databank, died, dissolution, DMF, eighteen, eleven, Enzon, explicit, exploit, Fayette, FDAAA, febuxostat, fifty, fraudulent, graph, headcount, hundred, hypersensitivity, illegal, implicit, improperly, incidence, Indemnity, intact, Interpreation, Ipsen, IRB, IRC, issuable, ITT, Joseph, Junior, juvenile, Kali, Kentucky, knowingly, language, mammalian, meaningful, Mechanically, mid, mild, moderate, molecule, Monte, necessity, nineteen, NOF, numerical, orderly, OTT, overlap, overpayment, partnership, payer, PDMA, pegloticase, PhRMA, plain, polypharmacy, preapproval, premised, prime, priori, proximate, pulled, ratified, reaction, recapture, recession, recordkeeping, recurring, referral, refined, registry, remuneration, Reorganization, residential, robust, Roxane, RTP, sampling, screening, SCV, Sim, simulation, sixteen, sixty, smallcap, stem, TAP, tentative, tentatively, thirteen, toxicity, twenty, uncertainly, unnecessary, unrecoverable, unsure, vanilla, vi, violate, widespread, willingly, withdrew, yearly, Zeb

Removed: abandon, accuracy, administering, aggregation, ameliorating, armed, auditing, authority, bought, broad, carryover, check, chronic, commenced, confidence, consisting, coordinate, denominated, department, drop, engineered, enrollment, establishment, exclude, failing, footnote, formed, forming, forward, frequently, Genentech, genetically, heavily, hormone, implemented, implementing, knowledge, lump, marking, maturity, maximize, monitoring, month, muscle, negatively, NJ, noncompliance, obstructive, paper, passage, payor, porcine, promising, proper, prosaptide, pulmonary, Qualifying, reintroduction, remediate, remediation, render, repaid, repositioning, representing, retirement, route, salary, segregation, Similarly, slower, subjected, sum, supported, symptomatic, targeting, turn, vaccine, wasting, workforce

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SVNT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EX -23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our report dated March 27, 2006 (except with respect to the matters described in the fourth paragraph, as to which the date is March 16, 2007), accompanying the consolidated financial statements and Schedule II included in the Annual Report of Savient Pharmaceuticals, Inc. on Form 10-K for the year ended December 31, 2007. We hereby consent to the incorporation by reference of said report in the Registration Statements of Savient Pharmaceuticals, Inc. on Forms S-8 (File No. 333-36121 effective August 7, 1997, File No. 333-33073 effective August 7, 1997, File No. 333-33075 effective September 22, 1997, File No. 333-64541 effective September 29, 1998, File No. 333-87344 effective May 1, 2002, File No. 333-127068 effective August 1, 2005) and Form S-3 (File No. 333-146257).

/s/ Grant Thorton LLP

New York, New York
March 13, 2008